Medication Therapy Management

Understanding the Basics of Pharmaceutical Compounding

June 23, 2023 - The healthcare industry relies heavily on pharmaceutical compounding, as it allows for personalized medication solutions to meet the specific requirements of individual patients. By delving into the vital components of pharmaceutical compounding, such as its importance, processes, and safety measures, PharmaNewsIntelligence underscores its significant impact on modern healthcare...

Read More


More Articles

Clinical Guidelines for Pediatric Obesity Encourage Early Intervention

by Veronica Salib

On January 9, 2023, the American Academy of Pediatrics (AAP) released its clinical practice guidelines for evaluating and treating pediatric obesity. These updated practices encourage comprehensive...

Clinical Pharmacists Are a Major Contributor to Quality Patient Care

by Veronica Salib

In recent years — especially considering the COVID-19 pandemic — the public has become increasingly aware of pharmacists’ role in healthcare. Despite the current prevalence of clinical pharmacists and their position on...

Decibel Therapeutics Announces Results of DB-020 Clinical Trial

by Veronica Salib

At the end of June, Decibel Therapeutics announced success in the phase 1b clinical trials on DB-020 for cancer patients receiving cisplatin chemotherapy. DB-020 is a sodium thiosulfate (STS) drug...

FDA Approves New Treatment for Large B-Cell Lymphoma

by Veronica Salib

Recently, the FDA approved a new second-line treatment for large B-cell lymphoma (LBCL). Lisocabtagene maraleucel is the generic name for Breyanzi, developed and marketed by Juno Therapeutics. As a...

GSK, Vir Dose First Patient in Phase 2/3 COVID-19 Antibody Study

by Samantha McGrail

GlaxoSmithKline (GSK) and Vir Biotechnology recently announced that the first patient was dosed in a Phase 2/3 study evaluating the safety and efficiency of a COVID-19 antibody treatment. The...

Anticoagulation Therapy Improves Outcomes for COVID-19 Patients

by Samantha McGrail

Mount Sinai researchers recently released additional information regarding the positive connection between anticoagulation therapy and improved survival among hospitalized COVID-19 patients. For more...

Patients Benefiting from Immune Checkpoint Inhibitor Drugs Limited

by Samantha McGrail

Slightly over a third of cancer patients are eligible for immune checkpoint inhibitor (ICI) drugs but even fewer are responding to the innovative treatment, according to researchers from Oklahoma State...

Recent Articles